Lanean...

New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs

Dyslipidaemias play a key role in determining cardiovascular risk; the discovery of statins has contributed a very effective approach. However, many patients do not achieve, at the maximal tolerated dose, the recommended goals for low-density lipoprotein-cholesterol (LDL-C), non-high-density lipopro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Norata, Giuseppe Danilo, Ballantyne, Christie M., Catapano, Alberico Luigi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857929/
https://ncbi.nlm.nih.gov/pubmed/23509227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/eht088
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!